Skip to search formSkip to main contentSkip to account menu

FK-506

Known as: FK 506, FK506 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryFK-506, a novel immunosuppressive agent, was examined for its reversing effect on multidrug-resistant tumor cells. FK-506… 
Highly Cited
1994
Highly Cited
1994
L-685,818 differs only slightly in structure from the immunosuppressive drug FK-506, and both compounds bind with comparable… 
Highly Cited
1993
Highly Cited
1993
FK-506 was evaluated either alone or combined with methotrexate (MTX) for prevention of graft-versus-host disease (GVHD) in dogs… 
1992
1992
FK-506-binding proteins (FKBPs), which in T cells are supposed to mediate the immunosuppressive effects of the compounds FK-506… 
Highly Cited
1989
Highly Cited
1989
Nanamolar concentrations of the immunosuppressive drug FK-506 inhibit the induction of T-lymphocyte proliferation by the lectins… 
Highly Cited
1987
Highly Cited
1987
FK is a potent immunosuppressive agent. FK can be analyzed in biologic fluids by EIA. The oral absorption of FK is rapid but… 
Highly Cited
1987
Highly Cited
1987
The immunosuppressive agent FK permitted increased kidney transplant survival in dogs over a wide dose range, but with weight…